Rankings
Publications
Search Publications
Cited-by Search
Sources
Publishers
Scholars
Scholars
Top Cited Scholars
Organizations
About
Scilit
About Us
Advisory Board
Data Sources
Career
Support / Contact
User Guide
Publisher User
Search Function
Rankings Function
API Resource
Scilit Knowledge
Metrics
Scilit Recognitions
Publications Classification
Media
News
Blog
Login
Register
Home
Publications
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance
Publication with shared reference
10.1016/j.diagmicrobio.2021.115314
Home
Publications
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance
Publication with shared reference
10.1016/j.diagmicrobio.2021.115314
Publications with shared reference:
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance
0
publications found
Export
Export
Analytics view
Analytics view
Scroll to top